Trial Profile
An open label, prospective study evaluating effect of budesonide (Pulmicort Turbuhaler) on interleukin-4 and interleukin-6 in exhaled breath condensate of patients with uncontrolled asthma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Feb 2017
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Pharmacodynamics; Therapeutic Use
- 15 Feb 2017 New trial record